Intellectual Property India Publishes Patent Application for 'Heterocyclic Compounds As Wrn Inhibitors' Filed by Synnovation Therapeutics, Inc.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517093332 A) filed by Synnovation Therapeutics, Inc., Wilmington, U.S.A., on Sept. 29, for 'heterocyclic compounds as wrn inhibitors.'

Inventor(s) include Yang, Jeffrey; Bai, Yu; He, Chunhong; Zhou, Fei; You, Lin; Mukai, Ken; Zheng, Hewen; Li, Yu; Zhang, Fenglei; Qi, Chao; Wu, Liangxing; and Yao, Wenqing.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "The present application provides heterocyclic compounds that modulate the activity of Werner syndrome helicase (WRN), and are useful in the treatment of various diseases, including cancer."

Th...